Renaissance Technologies’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.72M Buy
228,373
+21,000
+10% +$215K ﹤0.01% 1710
2025
Q4
$2.07M Sell
207,373
-15,492
-7% -$148K ﹤0.01% 1839
2025
Q3
$1.99M Sell
222,865
-3,400
-2% -$31.5K ﹤0.01% 2071
2025
Q2
$2.13M Sell
226,265
-186,100
-45% -$1.64M ﹤0.01% 2068
2025
Q1
$4.47M Buy
+412,365
New +$4.15M 0.01% 1501
2023
Q1
Sell
-53,165
Closed -$1.02M 3931
2022
Q4
$1.02M Sell
53,165
-105,800
-67% -$2.24M ﹤0.01% 2520
2022
Q3
$2.98M Buy
+158,965
New +$3.27M ﹤0.01% 1761
2021
Q3
Sell
-66,805
Closed -$1.83M 3434
2021
Q2
$1.83M Sell
66,805
-266,200
-80% -$7.59M ﹤0.01% 2316
2021
Q1
$12.2M Sell
333,005
-175,171
-34% -$6.19M 0.02% 1055
2020
Q4
$19.1M Buy
508,176
+131,676
+35% +$4.07M 0.02% 785
2020
Q3
$8.21M Buy
376,500
+181,600
+93% +$3.81M 0.01% 1272
2020
Q2
$3.14M Buy
194,900
+143,400
+278% +$2.4M ﹤0.01% 1912
2020
Q1
$824K Buy
+51,500
New +$728K ﹤0.01% 2519

Other funds holding AHCO

Renaissance Technologies's AHCO Position: Q1 2026 in Review

Renaissance Technologies increased its AdaptHealth (AHCO) stake by 10% in Q1 2026, buying an estimated $215K and bringing the position to 228,373 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

Renaissance Technologies first reported a position in AHCO in Q1 2020 and has held it in 13 quarters since. The position peaked at $19.1M in Q4 2020. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Renaissance Technologies held 228,373 shares of AdaptHealth worth $2.72M as of Q1 2026.
  • Renaissance Technologies bought 21,000 AdaptHealth shares in Q1 2026, an estimated $215K.
  • AdaptHealth made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1710 holding.
  • Renaissance Technologies first reported a position in AdaptHealth in Q1 2020 and has held it in 13 quarters since.
  • Renaissance Technologies's AdaptHealth position peaked at $19.1M in Q4 2020.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.